This is important because HDVax-induced inhibitory Tr1 cells and effector LDVax-induced helper CD4+ T express similar levels of CD39, suggesting that other factors beyond CD39 are required to differentiate between CD4+ T cells that inhibit versus promote tumour rejection54,55. The gene discussed is CD4; the disease is neoplasm.